Summit Global Investments’s Imperva, Inc. IMPV Stock Holding History

Summit Global Investments’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-15,300	Closed	-$711K	–	330
2018 Q3	$711K	Buy	15,300 +1,900	+14%	+$91.9K	0.1%	198
2018 Q2	$647K	Buy	13,400 +800	+6%	+$38.3K	0.1%	206
2018 Q1	$546K	Buy	+12,600	New	+$566K	0.09%	199

Other funds holding IMPV

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Summit Global Investments's IMPV Position: Q4 2018 in Review

Summit Global Investments sold out of Imperva, Inc. (IMPV) in Q4 2018, closing a stake of 15,300 shares — an estimated $711K sold.

Summit Global Investments first reported a position in IMPV in Q1 2018 and held it in 3 quarters. The position peaked at $711K in Q3 2018. 162 funds tracked by Wall St. Rank hold IMPV as of Q4 2018.

Summit Global Investments reported no remaining Imperva, Inc. position as of Q4 2018 after selling out during the quarter.
Summit Global Investments sold 15,300 Imperva, Inc. shares in Q4 2018, an estimated $711K.
Summit Global Investments first reported a position in Imperva, Inc. in Q1 2018 and held it in 3 quarters.
Summit Global Investments's Imperva, Inc. position peaked at $711K in Q3 2018.
162 funds tracked by Wall St. Rank held Imperva, Inc. as of Q4 2018.

Based on Summit Global Investments's 13F filing for Q4 2018, filed 8 Feb 2019.